Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT02752204

Conditions
Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal Liverpool University Hospital Liverpool, United Kingdom
  • University College London Hospitals London, United Kingdom
  • Guys Hospital London, United Kingdom
View Trial Details
Completed

Stem Cell Injection in Cancer Survivors

NCT02509156

Conditions
Breast Diseases, Breast Neoplasms, Cardiomyopathies, +18 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • University of Florida-Department of Medicine Gainesville, Florida, United States
  • University of Miami-Interdiciplinary Stem Cell Institute Miami, Florida, United States
  • Indiana Center for Vascular Biology and Medicine Indianapolis, Indiana, United States
View Trial Details
Completed

Whole-body MRI in Pediatric Hodgkin's Lymphoma

NCT04005703

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • LKH-Universitätsklinikum Graz Graz, Austria
  • Ospedale Giannina Gaslini Genova, Italy
  • Academic Medical Center Amsterdam Amsterdam, Netherlands
  • VU University Medical Center Amsterdam, Netherlands
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions